• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants.

作者信息

Lange Nicholas W, Salerno David M, Jennings Douglas L, Choe Jason, Hedvat Jessica, Kovac Danielle Bley, Scheffert Jenna, Shertel Tara, Ratner Lloyd E, Brown Robert S, Pereira Marcus R

机构信息

Department of Pharmacy, NewYork-Presbyterian Hospital Pharmacy, New York, New York, USA.

Department of Surgery, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.

出版信息

Am J Transplant. 2022 Jul;22(7):1925-1926. doi: 10.1111/ajt.16955. Epub 2022 Jan 19.

DOI:10.1111/ajt.16955
PMID:35015924
Abstract
摘要

相似文献

1
Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants.奈玛特韦/利托那韦的使用：处理与移植免疫抑制剂的具有临床意义的药物相互作用。
Am J Transplant. 2022 Jul;22(7):1925-1926. doi: 10.1111/ajt.16955. Epub 2022 Jan 19.
2
Single-center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression.在接受他克莫司维持免疫抑制治疗的肾移植受者中使用奈玛特韦/利托那韦的单中心经验。
Clin Transplant. 2022 Aug;36(8):e14752. doi: 10.1111/ctr.14752. Epub 2022 Jun 28.
3
A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case.一种 UPLC-MS/MS 法用于 SARS-CoV-2 感染背景下血浆中奈玛特韦和利托那韦的生物监测及其在 1 例病例中的应用。
J Am Soc Mass Spectrom. 2022 Oct 5;33(10):1975-1981. doi: 10.1021/jasms.2c00204. Epub 2022 Sep 9.
4
Drug Interactions With Direct-Acting Antivirals for Hepatitis C: Implications for HIV and Transplant Patients.丙型肝炎直接作用抗病毒药物的药物相互作用：对HIV和移植患者的影响。
Ann Pharmacother. 2015 Jun;49(6):674-87. doi: 10.1177/1060028015576180. Epub 2015 Mar 13.
5
Lopinavir/ritonavir: a review of its use in the management of HIV infection.洛匹那韦/利托那韦：其在HIV感染管理中的应用综述
Drugs. 2003;63(8):769-802. doi: 10.2165/00003495-200363080-00004.
6
Physiologically-Based Pharmacokinetic Modeling-Guided Dose Management of Oral Anticoagulants when Initiating Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 Treatment.基于生理的药代动力学模型指导下口服抗凝药物在 COVID-19 治疗中起始使用奈玛特韦/利托那韦（Paxlovid）的剂量管理。
Clin Pharmacol Ther. 2022 Oct;112(4):803-807. doi: 10.1002/cpt.2687. Epub 2022 Jul 4.
7
Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantation.恩夫韦肽：一种对肝移植后不久的人类免疫缺陷病毒感染患者安全有效的抗逆转录病毒药物。
Liver Transpl. 2009 Oct;15(10):1336-42. doi: 10.1002/lt.21818.
8
Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study.接受含利托那韦的 cART 的 HIV 感染患者移植前他克莫司药代动力学曲线：一项初步研究。
Transplantation. 2013 Jan 27;95(2):397-402. doi: 10.1097/TP.0b013e3182734651.
9
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT).新冠病毒感染者中奈玛特韦/利托那韦药物相互作用的管理：法国药理学和治疗学学会（SFPT）指南。
Therapie. 2022 Sep-Oct;77(5):509-521. doi: 10.1016/j.therap.2022.03.005. Epub 2022 Apr 20.
10
Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus.一名接受HIV挽救治疗和他克莫司的肾移植受者中的药物相互作用。
Am J Kidney Dis. 2009 Jul;54(1):e1-4. doi: 10.1053/j.ajkd.2009.01.268. Epub 2009 Apr 5.

引用本文的文献

1
Implementation of an Online Drug-Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19.为COVID-19的STRIVE恩昔瑞韦试验实施在线药物相互作用筛查工具
Open Forum Infect Dis. 2025 Jun 11;12(7):ofaf327. doi: 10.1093/ofid/ofaf327. eCollection 2025 Jul.
2
Optimized tacrolimus dosing strategy in kidney transplant recipients receiving nirmatrelvir-ritonavir for COVID-19.接受用于治疗COVID-19的奈玛特韦-利托那韦的肾移植受者的他克莫司优化给药策略
PLoS One. 2025 May 30;20(5):e0309875. doi: 10.1371/journal.pone.0309875. eCollection 2025.
3
Pharmacokinetic Interactions of Paxlovid Involving CYP3A Enzymes and P-gp Transporter: An Overview of Clinical Data.
帕罗韦德与CYP3A酶和P-糖蛋白转运体的药代动力学相互作用：临床数据概述
Curr Drug Metab. 2024;25(9):639-652. doi: 10.2174/0113892002320326250123082112.
4
Acute kidney injury and tacrolimus toxicity in a kidney transplant recipient treated with nirmaltrevir/ritonavir: a case report.接受奈玛特韦/利托那韦治疗的肾移植受者发生急性肾损伤和他克莫司毒性：一例报告
J Med Case Rep. 2024 Dec 20;18(1):629. doi: 10.1186/s13256-024-04990-6.
5
The effectiveness of nirmatrelvir/ritonavir regimen in hospitalized renal transplant patients with prolonged COVID-19 infection: a multicenter clinical experience.奈玛特韦/利托那韦方案对新冠病毒感染迁延不愈的住院肾移植患者的有效性：一项多中心临床经验
Ren Fail. 2024 Dec;46(2):2385724. doi: 10.1080/0886022X.2024.2385724. Epub 2024 Sep 16.
6
Paxlovid (Nirmatrelvir/Ritonavir)-Induced Tacrolimus Toxicity in Organ Transplant Recipients - A Review on Drug Interactions Involving CYP3A Enzymes.帕罗韦德（奈玛特韦/利托那韦）诱导器官移植受者发生他克莫司毒性——关于涉及CYP3A酶的药物相互作用的综述
Curr Drug Saf. 2025;20(3):291-302. doi: 10.2174/0115748863331165240821194206.
7
Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study.用于合理使用奈玛特韦/利托那韦的药物相互作用管理系统评估：一项回顾性观察研究。
J Pharm Health Care Sci. 2024 Sep 3;10(1):54. doi: 10.1186/s40780-024-00376-4.
8
Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus.病例报告及文献综述：系统性红斑狼疮患者中帕罗韦德（奈玛特韦/利托那韦）诱发急性他克莫司毒性的管理
Front Pharmacol. 2024 Jun 19;15:1364121. doi: 10.3389/fphar.2024.1364121. eCollection 2024.
9
Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients.奈玛特韦/利托那韦在肾移植受者中的药代动力学和与钙调磷酸酶抑制剂的药物相互作用。
Eur J Clin Pharmacol. 2024 Aug;80(8):1219-1227. doi: 10.1007/s00228-024-03691-9. Epub 2024 May 1.
10
Ritonavir: 25 Years' Experience of Concomitant Medication Management. A Narrative Review.利托那韦：25年的联合用药管理经验。一篇叙述性综述。
Infect Dis Ther. 2024 May;13(5):1005-1017. doi: 10.1007/s40121-024-00959-6. Epub 2024 Apr 12.